Yang Xurong, Li Li, Ren Xiaonan, Nie Lixiong
Jiangle County General Hospital, Sanming, China.
Department of Rehabilitation, Mawei District Hospital, Fuzhou, China.
Bone Joint Res. 2022 Mar;11(3):171-179. doi: 10.1302/2046-3758.113.BJR-2021-0350.R1.
There is conflicting evidence on the safety of intra-articular injections of hyaluronic acid (HA) or corticosteroids (CSs) before total knee arthroplasty (TKA). We performed a meta-analysis of the relationship between intra-articular injections and subsequent infection rates after TKA.
We searched PubMed, EMBASE, and the Cochrane Library for cohort studies that assessed the effect of preoperative injection of drugs into the joint cavity on the infection rate after TKA. The outcomes analyzed included the total infection rate, as well as those for different preoperative injection time periods and different drugs.
Eight studies, including 73,880 in the injection group and 126,187 in the control group, met the inclusion criteria. The injection group had a significantly higher postoperative infection rate than the control group (risk ratio (RR) 1.16; 95% confidence interval (CI) 1.07 to 1.27; p < 0.001; I = 32%). For patients who received injections up to three months preoperatively, the postoperative infection risk was significantly higher than that in the control group (RR 1.26; 95% CI 1.18 to 1.35; p<0.001; I = 0%). There was no significant difference in the infection rates between the four-to-six-month injection and control groups (RR 1.12; 95% CI 0.93 to 1.35; p = 0.240; I = 75%) or between the seven-to-12-month injection and control groups (RR 1.02; 95% CI 0.94 to 1.12; p = 0.600; I = 0%).
Current evidence suggests that intra-articular injections of CSs or HA before TKA increase the risk of postoperative infection. Injections administered more than three months before TKA do not significantly increase the risk of infection. Cite this article: 2022;11(3):171-179.
关于全膝关节置换术(TKA)前关节腔内注射透明质酸(HA)或皮质类固醇(CSs)的安全性,证据存在冲突。我们对TKA后关节腔内注射与后续感染率之间的关系进行了荟萃分析。
我们在PubMed、EMBASE和Cochrane图书馆中检索了队列研究,这些研究评估了术前向关节腔内注射药物对TKA后感染率的影响。分析的结果包括总感染率,以及不同术前注射时间段和不同药物的感染率。
八项研究符合纳入标准,其中注射组73880例,对照组126187例。注射组术后感染率显著高于对照组(风险比(RR)1.16;95%置信区间(CI)1.07至1.27;p<0.001;I²=32%)。对于术前三个月内接受注射的患者,术后感染风险显著高于对照组(RR 1.26;95%CI 1.18至1.35;p<0.001;I²=0%)。四至六个月注射组与对照组的感染率无显著差异(RR 1.12;95%CI 0.93至1.35;p = 0.240;I²=75%),七至十二个月注射组与对照组的感染率也无显著差异(RR 1.02;95%CI 0.94至1.12;p = 0.600;I²=0%)。
目前的证据表明,TKA前关节腔内注射CSs或HA会增加术后感染风险。TKA前三个月以上进行的注射不会显著增加感染风险。引用本文:2022;11(3):171-179。